Adaptimmune Therapeutics plc Stock Forecast
Volatile ride for Adaptimmune Therapeutics plc stock price on Tuesday moving between $1.01 and $1.16
(Updated on Apr 23, 2024)
The Adaptimmune Therapeutics plc stock price gained 12.87% on the last trading day (Tuesday, 23rd Apr 2024), rising from $1.01 to $1.14. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 15.42% from a day low at $1.01 to a day high of $1.16. The price has fallen in 6 of the last 10 days and is down by -16.79% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 437 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.29 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.38% during the next 3 months and, with a 90% probability hold a price between $1.01 and $2.05 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ADAP Signals & Forecast
There are mixed signals in the stock today. The Adaptimmune Therapeutics plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.37. On a fall, the stock will find some support from the short-term average at $1.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -34.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Adaptimmune Therapeutics plc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Adaptimmune Therapeutics plc stock
On the downside, the stock finds support just below today's level from accumulated volume at $1.00 and $0.96. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adaptimmune Therapeutics plc finds support just below today's level at $1.00. If this is broken, then the next support from accumulated volume will be at $0.96 and $0.87.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.155 between high and low, or 15.42%. For the last week, the stock has had daily average volatility of 14.39%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ADAP) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Adaptimmune Therapeutics plc to open at $1.10, and during the day (based on 14 day Average True Range), to move between $1.00 and $1.28, which gives a possible trading interval of +/-$0.140 (+/-12.26%) up or down from last closing price. If Adaptimmune Therapeutics plc takes out the full calculated possible swing range there will be an estimated 24.52% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.17 (2.63%) than the support at $1.00 (12.28%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Adaptimmune Therapeutics plc stock A Buy?
Adaptimmune Therapeutics plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -3.427 Sell Candidate Unchanged
Predicted Opening Price for Adaptimmune Therapeutics plc of Wednesday, April 24, 2024
Fair opening price April 24, 2024 | Current price |
---|---|
$1.10 ( 3.36%) | $1.14 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ADAP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.26 | 10.23 % | |
R2 | 1.20 | 5.04 % | ||
R1 | 1.16 | 1.83 % | ||
Current price: | 1.14 | |||
Support | S1 | 1.04 | -8.56 % | |
S2 | 1.01 | -11.77 % | ||
S3 | 0.95 | -16.96 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.38 | 21.05 % | |
R2 | 1.33 | 16.67 % | ||
R1 | 1.17 | 2.63 % | ||
Current price | 1.14 | |||
Support | S1 | 1.00 | -12.28% | |
S2 | 0.96 | -15.79% | ||
S3 | 0.87 | -23.26% |
FAQ
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.